In summary, the data from our study demonstrate that marked weight loss improves β cell function, defined as insulin secretion in relation to plasma glucose, in people with obesity and T2D, and the effect of weight loss induced by RYGB surgery on β cell function is not different from the effect of matched weight loss induced by a LCD alone. Here, INS is linked to obesity disorder.